At Jacob Bonham we are a firm of dedicated professionals focused on providing growth and new revenue strategies, business valuation, and M&A transaction advisory services for the diagnostic laboratory industry.

https://neogenomics.com/diagnostic-services/laboratory-collaborationNeoGenomics, in addition to offering world class Oncology based testing, collaborates with community oncology practices to offer clinical, operational and financial benefits of internalizing portions of their send out testing. We offer the advantage of working with respected Pathology peers locally who can read cases that are done through NeoGenomics robust tech-only platform.

NeoGenomics, along with offering a broad range of Oncology based testing, collaborates with Oncology groups to internalize a portion of their send out testing to offer the clinic the clinical, operational and financial benefit of these services. We have helped many clinics who have a strong desire for independence, do just that, stay independent.

Dako, an Agilent Technologies Company, is a global leader in tissue-based cancer diagnostics and provides instruments, reagents and software for high quality cancer diagnosis and efficient laboratory processes. These solutions are utilized in the hospital and research areas of Anatomical Pathology, Molecular and Histology. Directly responsible for managing five Territory Managers throughout the Southeast US and Puerto Rico. Continually ranked #1 for capital sales and consistently met or exceeded quota growth. Well versed with Situational Leadership and Consultative selling. Highly motivated dynamic leader who inspires the team for top performance.• #1 in capital sales 2013/2014/2015.• Managed 5 Territory Managers and 5 Technical Specialists• Consistently in the top 2 regions nationally• Instrumental setting Key Strategic Objectives for the team and Nation• Instituted a TAM (Total Available Market) analysis to focus efforts to customers in the buying cycle• Utilized workflow and six sigma to improve lab efficiencies to sell total portfolio of solutions• In the midst of major backorder, maintained team’s motivation and achieved highest growth in the nation• Successfully covered corporate accounts.

Driving the broad and expanded utilization by pathologists in an expansion 11 state region of the p16INK4a antibody for the early identification of oncogenic activity in cervical biopsies through in-depth clinical conversations utilizing and referencing third party peer reviewed proof sources, building of customer relationships and consultative status, customized clinical presentations, and hosting luminary presentations. Also responsible for identifying and developing national key opinion leaders as well as local heroes.MTM is a developer and manufacturer of products for the early detection and diagnosis of cervical and other cancers. Headquartered in Heidelberg, Germany, mtm markets proprietary diagnostic and early detection technologies for cervical cancer.• Overall territory growth of 232% since inception.• Number one region in territory growth 2009.• Consistently in the top 3 reps nationwide for territory growth through my tenure.• Longest tenured representative within the organizations 8 year history.• Trained every representative in the organization.• Only field representative invited to be involved in setting long term sales plans with senior management.• Only field representative to present strategy and planning to the field reps during regional meetings.• Only field representative invited to participate in high level training at corporate office in Germany.

Manage book of business equal to $4,750,000 in equipment and $23,000,000 in reagents through the mid Atlantic and South East Regions. Finally tuned management skills in developing new representatives and assisting seasoned sales professionals to reach their greatest potential. As a mentor, 2 representatives were promoted within the organization. Keen focus on forecast management, expense minimization protocols and Sales Force Automation software to manage the regions contribution to maximize company margin.• Number one region for instrument growth (148% for 2007)• Managed 4 Sales Specialists and 5 Technical consultants.• Implemented mentor strategies and growth metrics to help achieve goal.• Consistently maintained expense budget below quota • Profitability contribution margin ahead of national average (12/2007)• Involved in leading and implementing new tracking and sales tools (Install implementation grid 2/2008)• Chosen to be the beta region for new product launch (4/2008)

Managed the sale of blood separation and blood storage medical devices and supplies for the blood bank industry and hospital markets. Call points were CEO, COO, CFO, MD, PHD, Directors and top managers. Successful in starting new territory by developing forecasts, working to a plan and achieving sales quotas.• Ranked number one sales rep in east region and number 3 nationwide.• Achieved 109% of sales goal.• Increase revenue over prior year by 40%.• Grew revenue in territory by 75% in Q4.• Increased business by placing 42% more machines in territory.• Use highly effective SPIN sales techniques and questioning.

Marketed and sold insulin pump therapy to physicians, diabetes nurse educators and patients in a start-up territory from Gainesville to Naples, Florida. Call points were endocrinologists, cardiologists, nephrologists, ophthalmologists, internal medicine, general practice physicians, certified diabetes educators, dietitians, nurses and patients. • Doubled sales over prior year.• Number one sales representative for new territories in the United States.• Achieved sales goals by increasing sales of insulin pumps from 0 pumps per month to an average of 15 pumps per month. • Instituted insulin pump support groups and member of several diabetes education associations.• Well versed in managed care and government accounts.